This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted.DXVX is taking...
In this free webinar, gain insight into why US-based biopharmaceutical manufacturing is strategically advantageous. Attendees will learn how complicated tech-transfers...
In this free webinar, learn how to harness integrated functional multi-omics to enhance translational confidence and de-risk early-stage drug development...
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Bronchiectasis ORLANDO, FL / ACCESS Newswire /...
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy WASHINGTON, D.C. /...
Live results announced today in Melbourne at HIC 2025, Australia's largest digital health and health informatics industry gathering MELBOURNE, AU...
Powered by OpenAI's Reinforcement Fine-Tuning technology, this first-in-class AI copilot delivers real-time, patient-specific, evidence-based insights, directly within the EHR, underpinned...
MESA, ARIZONA / ACCESS Newswire / August 18, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) recently announced that its...
Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applicationsIrvine Labs progresses development of proprietary...
According to the NIH, Acute myocardial infarction (AMI) is a major cause of death, affecting nearly 3 million Americans each...
SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”),...
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)...
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical...
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18,...
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and...
CARAC (fluorouracil cream), 0.5% . ...
NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of...
· Collaboration strengthens Boehringer’s pipeline in Eye Health.· Many patients with diabetic retinopathy (DR) continue to experience vision loss or...
-Completes Two Financings, Raising $6.5 Million- -Regains Compliance for Continued Listing on Nasdaq- -Announces Management Changes; Adds Two New Board...